Rapid Diagnostek Receives $4,635,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Rapid Diagnostek
  • Mailing Address
    1301 Gateway Circle Hudson, WI 54016
  • Company Description
    Rapid Diagnostek is utilizing proprietary technology to develop a new generation of in vitro diagnostic tests through the use of our patented RFPS (radio frequency phase shift) detection technology and our disposable IntelliProbe Immunosensor (IPI). We are making this elegantly simple technology platform available for licensing by companies in the human health, veterinary medical, food safety, and environmental testing markets. Our technology is useful for performing tests that are sensitive and specific, easy to use and interpret, provide results in minutes, are cost effective, and require no added reagents.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy